NHL Clinical Trials | OpenTrials

Active, not recruiting

Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma

NCT03789240

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, not recruiting

The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL

NCT03463057

Conditions: DLBCL, NHL
Locations: BE-Antwerpen Edegem-UZA Antwerp, Belgium

BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium

BE-Brugge-AZBRUGGE Bruges, Belgium

BE-Leuven-UZLEUVEN Leuven, Belgium

View all 32 locations

View Trial Details

Active, not recruiting

A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)

NCT05879744

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

Winship Cancer Institute at Emory University Atlanta, Georgia, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

NCT02315612

Conditions: ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies

NCT05371054

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL

NCT04555811

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +12 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

Washington University School of Medicine - Siteman Cancer Center St Louis, Missouri, United States

View Trial Details

Completed

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

NCT03527147

Conditions: DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations: Research Site Los Angeles, California, United States

Research Site Sarasota, Florida, United States

Research Site Atlanta, Georgia, United States

Research Site New Orleans, Louisiana, United States

View Trial Details

Completed

Safety Study of NHL With 90Y-hLL2 IgG

NCT00421395

Conditions: B-cell NHL, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Research Unit 463 INSERM Nantes, Cedex, France

Service des Maladies du Sang Lille, France

University Hospital Dresden Dresden, Germany

Klinikum der Georg-August-Universitat Gottingen Göttingen, Germany

View Trial Details

Completed

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

NCT00546793

Conditions: CLL, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +35 more
Locations: Lewis Cancer Center and Research Pavilion Savannah, Georgia, United States

Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A. Denville, New Jersey, United States

Morristown Memorial Hospital Morristown, New Jersey, United States

New York Hospital Weill Cornell Medical Center New York, United States

View Trial Details

Completed

Influence of Corn Farming on the Immune System

NCT00342121

Conditions: NHL, Neoplasms
Locations: University of Iowa Iowa City, Iowa, United States

View Trial Details

NHL

NHL trial results

Related conditions